Zions Bancorporation’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.25M | Buy |
9,554
+3,388
| +55% | +$474K | 0.08% | 201 |
|
|
2024
Q3 | $961K | Buy |
6,166
+1,636
| +36% | +$264K | 0.07% | 204 |
|
|
2024
Q2 | $707K | Buy |
4,530
+3,650
| +415% | +$549K | 0.06% | 216 |
|
|
2024
Q1 | $119K | Sell |
880
-44
| -5% | -$5.83K | 0.01% | 353 |
|
|
2023
Q4 | $124K | Sell |
924
-14
| -1% | -$1.82K | 0.01% | 349 |
|
|
2023
Q3 | $127K | Sell |
938
-6
| -0.6% | -$819 | 0.01% | 331 |
|
|
2023
Q2 | $135K | Sell |
944
-1,216
| -56% | -$179K | 0.01% | 331 |
|
|
2023
Q1 | $300K | Sell |
2,160
-828
| -28% | -$111K | 0.03% | 278 |
|
|
2022
Q4 | $405K | Buy |
2,988
+326
| +12% | +$40.9K | 0.03% | 259 |
|
|
2022
Q3 | $292K | Buy |
2,662
+1,568
| +143% | +$199K | 0.03% | 275 |
|
|
2022
Q2 | $144K | Buy |
1,094
+24
| +2% | +$3.15K | 0.01% | 341 |
|
|
2022
Q1 | $142K | Buy |
1,070
+57
| +6% | +$6.84K | 0.01% | 368 |
|
|
2021
Q4 | $118K | Sell |
1,013
-6
| -0.6% | -$706 | 0.01% | 358 |
|
|
2021
Q3 | $122K | Sell |
1,019
-362
| -26% | -$42.1K | 0.01% | 345 |
|
|
2021
Q2 | $165K | Buy |
1,381
+95
| +7% | +$10.4K | 0.02% | 308 |
|
|
2021
Q1 | $128K | Sell |
1,286
-2,705
| -68% | -$272K | 0.01% | 318 |
|
|
2020
Q4 | $399K | Sell |
3,991
-142
| -3% | -$15K | 0.05% | 156 |
|
|
2020
Q3 | $453K | Buy |
4,133
+294
| +8% | +$32.7K | 0.06% | 123 |
|
|
2020
Q2 | $406K | Sell |
3,839
-521
| -12% | -$53.8K | 0.06% | 126 |
|
|
2020
Q1 | $389K | Buy |
4,360
+262
| +6% | +$24.7K | 0.07% | 108 |
|
|
2019
Q4 | $409K | Sell |
4,098
-588
| -13% | -$55.4K | 0.06% | 124 |
|
|
2019
Q3 | $418K | Buy |
+4,686
| New | +$406K | 0.06% | 131 |
|
|
2018
Q4 | – | Sell |
-10,608
| Closed | -$839K | – | 514 |
|
|
2018
Q3 | $839K | Buy |
+10,608
| New | +$802K | 0.2% | 66 |
|
|
2017
Q4 | – | Sell |
-19,426
| Closed | -$1.32M | – | 638 |
|
|
2017
Q3 | $1.32M | Buy |
19,426
+18,737
| +2,719% | +$1.18M | 0.19% | 74 |
|
|
2017
Q2 | $47K | Buy |
689
+19
| +3% | +$1.24K | 0.01% | 218 |
|
|
2017
Q1 | $43K | Sell |
670
-336
| -33% | -$19.6K | 0.01% | 205 |
|
|
2016
Q4 | $55K | Sell |
1,006
-406
| -29% | -$23.1K | 0.01% | 222 |
|
|
2016
Q3 | $91K | Buy |
1,412
+390
| +38% | +$25.5K | 0.02% | 171 |
|
|
2016
Q2 | $61K | Sell |
1,022
-391
| -28% | -$22.7K | 0.01% | 196 |
|
|
2016
Q1 | $82K | Sell |
1,413
-5
| -0.4% | -$300 | 0.01% | 181 |
|
|
2015
Q4 | $88K | Buy |
1,418
+45
| +3% | +$2.95K | 0.02% | 160 |
|
|
2015
Q3 | $87K | Buy |
1,373
+973
| +243% | +$64K | 0.02% | 154 |
|
|
2015
Q2 | $25K | Sell |
400
-1,064
| -73% | -$72.8K | ﹤0.01% | 200 |
|
|
2015
Q1 | $100K | Buy |
+1,464
| New | +$102K | 0.02% | 167 |
|
Other funds holding AZN
Zions Bancorporation's AZN Position: Q4 2024 in Review
Zions Bancorporation increased its AstraZeneca (AZN) stake by 55% in Q4 2024, buying an estimated $474K and bringing the position to 9,554 shares worth $1.25M. The position accounts for 0.08% of the portfolio, ranked #201.
Zions Bancorporation first reported a position in AZN in Q1 2015 and has held it in 34 quarters since. The position peaked at $1.32M in Q3 2017. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.
- Zions Bancorporation held 9,554 shares of AstraZeneca worth $1.25M as of Q4 2024.
- Zions Bancorporation bought 3,388 AstraZeneca shares in Q4 2024, an estimated $474K.
- AstraZeneca made up 0.08% of Zions Bancorporation's portfolio in Q4 2024, its #201 holding.
- Zions Bancorporation first reported a position in AstraZeneca in Q1 2015 and has held it in 34 quarters since.
- Zions Bancorporation's AstraZeneca position peaked at $1.32M in Q3 2017.
- 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.